Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice

Journal of Neuroinflammation

Volumn 6, Issue , 2009, Pages

  Stahel, Philip F ^a   Flierl, Michael A ^a   Morgan, B Paul ^b   Persigehl, Ivonne ^c   Stoll, Christiane ^c   Conrad, Claudia ^c   Touban, Basel M ^a   Smith, Wade R ^a   Beauchamp, Kathryn ^a   Schmidt, Oliver I ^d   Ertel, Wolfgang ^c   Leinhase, Iris ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Klinikum St Georg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENT MEMBRANE ATTACK COMPLEX; FAS ANTIGEN; FAS LIGAND; NEURON SPECIFIC ENOLASE; PROTEIN BAX; PROTEIN BCL 2; ENOLASE; FAS PROTEIN, MOUSE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN PROTECTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE EXACERBATION; GENE DELETION; GENE EXPRESSION; MOUSE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NICK END LABELING; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING; WILD TYPE; ANIMAL; APOPTOSIS; BRAIN; BRAIN INJURY; C57BL MOUSE; DEMYELINATING DISEASE; DISEASE MODEL; GENETICS; METABOLISM; MOUSE MUTANT; NERVE CELL; PATHOLOGY;

ANIMALS; ANTIGENS, CD59; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN; BRAIN INJURIES; COMPLEMENT MEMBRANE ATTACK COMPLEX; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER;

EID: 60649094952     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-6-2     Document Type: Article

References (42)

1. Morgan BP Gasque P Singhrao SK Piddlesden SJ Role of complement in inflammation and injury in the nervous system Exp Clin Immunogenet 1997, 14(1):19-23. 9187919
2. Stahel PF Morganti-Kossmann MC Kossmann T The role of the complement system in traumatic brain injury Brain Res Rev 1998, 27(3):243-256. 10.1016/S0165-0173(98)00015-0 9729408
3. Stahel PF Morganti-Kossmann MC Perez D Redaelli C Gloor B Trentz O Kossmann T Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury J Neurotrauma 2001, 18(8):773-781. 10.1089/089771501316919139 11526983
4. Stahel PF Barnum SR The role of the complement system in CNS inflammatory diseases Expert Rev Clin Immunol 2006, 2:445-456. 10.1586/ 1744666X.2.3.445
5. Morgan BP Regulation of the complement membrane attack pathway Crit Rev Immunol 1999, 19(3):173-198. 10422598
6. Kimberley FC Sivasankar B Paul Morgan B Alternative roles for CD59 Mol Immunol 2007, 44(1-3):73-81. 10.1016/j.molimm.2006.06.019 16884774
7. Singhrao SK Neal JW Rushmere NK Morgan BP Gasque P Differential expression of individual complement regulators in the brain and choroid plexus Lab Invest 1999, 79(10):1247-1259. 10532588
8. Singhrao SK Neal JW Rushmere NK Morgan BP Gasque P Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis Am J Pathol 2000, 157(3):905-918. 1885712 10980130
9. Mead RJ Singhrao SK Neal JW Lassmann H Morgan BP The membrane attack complex of complement causes severe demyelination associated with acute axonal injury J Immunol 2002, 168(1):458-465. 11751993
10. Cole DS Hughes TR Gasque P Morgan BP Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis Mol Immunol 2006, 43(12):1953-1964. 10.1016/j.molimm.2005.11.015 16406094
11. Wei EP Lamb GR Kontos HA Increased phospholipase C activity after experimental brain injury J Neurosurg 1982, 56:695-698. 7069482
12. Bellander BM Singhrao SK Ohlsson M Mattsson P Svensson M Complement activation in the human brain after traumatic head injury J Neurotrauma 2001, 18:1295-1311. 10.1089/08977150152725605 11780861
13. Baalasubramanian S Harris CL Donev RM Mizuno M Omidvar N Song WC Morgan BP CD59a is the primary regulator of membrane attack complex assembly in the mouse J Immunol 2004, 173:3684-3692. 15356114
14. Donev RM Sivasankar B Mizuno M Morgan BP The mouse complement regulator CD59b is significantly expressed only in testis and plays roles in sperm acrosome activation and motility Mol Immunol 2008, 45:534-542. 1995235 17597212 10.1016/j.molimm.2007.05.011
15. Mead RJ Neal JW Griffiths MR Linington C Botto M Lassmann H Morgan BP Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis Lab Invest 2004, 84(1):21-28. 10.1038/ labinvest.3700015 14631387
16. Holt DS Botto M Bygrave AE Hanna SM Walport MJ Morgan BP Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria Blood 2001, 98:442-449. 10.1182/blood.V98.2.442 11435315
17. Chen Y Constantini S Trembovler V Weinstock M Shohami E An experimental model of closed head injury in mice: Pathophysiology, histopathology, and cognitive deficits J Neurotrauma 1996, 13:557-568. 8915907
18. Tsenter J Beni-Adani L Assaf Y Alexandrovich AG Trembovler V Shohami E Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions J Neurotrauma 2008, 25(4):324-333. 10.1089/ neu.2007.0452 18373482
19. Beni-Adani L Gozes I Cohen Y Assaf Y Steingart RA Brenneman DE Eizenberg O Trembolver V Shohami E A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice J Pharmacol Exp Ther 2001, 296(1):57-63. 11123362
20. Stahel PF Shohami E Younis FM Kariya K Otto VI Lenzlinger PM Grosjean MB Eugster HP Trentz O Kossmann T Morganti-Kossmann MC Experimental closed head injury: Analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines J Cereb Blood Flow Metab 2000, 20:369-380. 10.1097/00004647-200002000-00019 10698075
21. Rancan M Morganti-Kossmann MC Barnum SR Saft S Schmidt OI Ertel W Stahel PF Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice J Cereb Blood Flow Metab 2003, 23(9):1070-1074. 10.1097/ 01.WCB.0000084250.20114.2C 12973023
22. Berger RP Beers SR Richichi R Wiesman D Adelson PD Serum biomarker concentrations and outcome after pediatric traumatic brain injury J Neurotrauma 2007, 24:1793-1801. 10.1089/neu.2007.0316 18159990
23. Leinhase I Holers VM Thurman JM Harhausen D Schmidt OI Pietzcker M Taha ME Rittirsch D Huber-Lang M Smith WR Ward PA Stahel PF Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation BMC Neurosci 2006, 7:55. 1540436 16842619 10.1186/1471-2202-7-55
24. Leinhase I Rozanski M Harhausen D Thurman JM Schmidt OI Hossini AM Taha ME Rittirsch D Ward PA Holers VM Ertel W Stahel PF Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: A randomized placebo-controlled study in mice J Neuroinflammation 2007, 4:13. 1867808 17474994 10.1186/ 1742-2094-4-13
25. Leinhase I Schmidt OI Thurman JM Hossini AM Rozanski M Taha ME Scheffler A John T Smith WR Holers VM Stahel PF Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury Exp Neurol 2006, 199(2):454-464. 10.1016/ j.expneurol.2006.01.033 16545803
26. Farkas I Baranyi L Liposits ZS Yamamoto T Okada H Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells Neuroscience 1998, 86:903-911. 10.1016/S0306-4522(98)00108-0 9692726
27. Niculescu T Weerth S Soane L Niculescu F Rus V Raine CS Shin ML Rus H Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis Ann NY Acad Sci 2003, 1010:530-533. 10.1196/annals.1299.098 15033785
28. You Z Yang J Takahashi K Yager PH Kim HH Qin T Stahl GL Ezekowitz RA Carroll MC Whalen MJ Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4 J Cereb Blood Flow Metab 2007, 27:1954-1964. 10.1038/sj.jcbfm.9600497 17457366
29. Yager PH You Z Qin T Kim HH Takahashi K Ezekowitz AB Stahl GL Carroll MC Whalen MJ Mannose binding lectin gene deficiency increases susceptibility to traumatic brain injury in mice J Cereb Blood Flow Metab 2008, 28(5):1030-1039. 10.1038/sj.jcbfm.9600605 18183030
30. Müller-Eberhard HJ The killer molecule of complement J Invest Dermatol 1985, 85(Suppl 1):47s-52s. 10.1111/1523-1747.ep12275445
31. Casarsa C De Luigi A Pausa M De Simoni MG Tedesco F Intracerebroventricular injection of terminal complement complex causes inflammatory reaction in the rat brain Eur J Immunol 2003, 33:1260-1270. 10.1002/eji.200323574 12731051
32. Xiong ZQ Qian W Suzuki K McNamara JO Formation of complement membrane attack complex in Mammalian cerebral cortex evokes seizures and neurodegeneration J Neurosci 2003, 23(3):955-960. 12574424
33. Lindsberg PJ Ohman J Lehto T Karjalainen-Lindsberg ML Paetau A Wuorimaa T Carpen O Kaste M Meri S Complement activation in the central nervous system following blood-brain barrier damage in man Ann Neurol 1996, 40(4):587-596. 10.1002/ana.410400408 8871578
34. Bellander BM von Holst H Fredman P Svensson M Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat J Neurosurg 1996, 85(3):468-475. 8751634
35. Turnberg D Botto M Lewis M Zhou W Sacks SH Morgan BP Walport MJ Cook HT CD59a deficiency exacerbates ischemia-reperfusion injury in mice Am J Pathol 2004, 165(3):825-832. 1618586 15331407
36. Beauchamp K Mutlak H Smith WR Shohami E Stahel PF Pharmacology of traumatic brain injury - where is the "golden bullet"? Mol Med 2008, 14:731-740. 2527342 18769636 10.2119/2008-00050.Beauchamp
37. Barnum SR Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease Mol Med 1999, 5(9):569-582. 2230464 10551898
38. Sahu A Lambris JD Complement inhibitors: A resurgent concept in anti-inflammatory therapeutics Immunopharmacology 2000, 49(1-2):133-148. 10.1016/S0162-3109(00)80299-4 10904113
39. Morgan BP Harris CL Complement therapeutics: History and current progress Mol Immunol 2003, 40:159-170. 10.1016/S0161-5890(03)00111-1 12914822
40. Holers VM Thurman JM The alternative pathway of complement in disease: opportunities for therapeutic targeting Mol Immunol 2004, 41:147-152. 10.1016/j.molimm.2004.03.012 15159060
41. Kaczorowski SL Schiding JK Toth CA Kochanek PM Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats J Cereb Blood Flow Metab 1995, 15(5):860-864. 7673379
42. Huang Y Smith CA Song H Morgan BP Abagyan R Tomlinson S Insights into the human CD59 complement binding interface toward engineering new therapeutics J Biol Chem 2005, 280(40):34073-34079. 10.1074/ jbc.M504922200 16079145